One of the products of EPC is leukemia inhibitory factor, which itself activated the STAT3 pathway and mitigated formation of myofibroblasts, whereas a more potent gp130/STAT3 agonist, a fusion protein hyper‐IL‐6, also prevented renal fibrosis. Here, LIF is linked to renal fibrosis.